{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:16:03Z","timestamp":1773249363537,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Injecting drug users (IDUs) in Taiwan contributed significantly to an HIV\/AIDS epidemic in 2005. In addition, studies that identified risk factors of HCV\/HIV co-infection among IDUs were sparse. This study aimed to identify risk factors of HCV\/HIV co-infection and HCV mono-infection, as compared with seronegativity, among injecting drug users (IDUs) at a large methadone maintenance treatment program (MMTP) in Taipei, Taiwan.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Data from enrollment interviews and HCV and HIV testing completed by IDUs upon admission to the Taipei City Hospital MMTP from 2006\u20132010 were included in this cross-sectional analysis. HCV and HIV testing was repeated among re-enrollees whose HCV or HIV test results were negative at the preceding enrollment. Backward stepwise multinomial logistic regression was used to identify risk factors associated with HCV\/HIV co-infection and HCV mono-infection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of the 1,447 IDUs enrolled, the prevalences of HCV\/HIV co-infection, HCV mono-infection, and HIV mono-infection were 13.1%, 78.0%, and 0.4%, respectively. In backward stepwise multinomial regression analysis, after controlling for potential confounders, syringe sharing in the 6 months before MMTP enrollment was significantly positively associated with HCV\/HIV co-infection (adjusted odds ratio [AOR]=27.72, 95% confidence interval [CI] 13.30\u201357.76). Incarceration was also significantly positively associated with HCV\/HIV co-infection (AOR=2.01, 95% CI 1.71\u20132.37) and HCV mono-infection (AOR=1.77, 95% CI 1.52\u20132.06), whereas smoking amphetamine in the 6 months before MMTP enrollment was significantly inversely associated with HCV\/HIV co-infection (AOR=0.44, 95% CI 0.25\u20130.76) and HCV mono-infection (AOR=0.49, 95% CI 0.32\u20130.75). HCV seroincidence was 45.25\/100 person-years at risk (PYAR; 95% CI 24.74\u201375.92\/100 PYAR) and HIV seroincidence was 0.53\/100 PYAR (95% CI 0.06\u20131.91\/100 PYAR) among re-enrolled IDUs who were HCV- or HIV-negative at the preceding enrollment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>IDUs enrolled in Taipei MMTPs had very high prevalences of HCV\/HIV co-infection and HCV mono-infection. Interventions such as expansion of syringe exchange programs and education regarding HCV\/HIV prevention should be implemented for this high-risk group of drug users.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2458-12-1066","type":"journal-article","created":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T03:19:28Z","timestamp":1355195968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prevalences and associated risk factors of HCV\/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan"],"prefix":"10.1186","volume":"12","author":[{"given":"Yung-Feng","family":"Yen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muh-Yong","family":"Yen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lien-Wen","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan-Huei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peing","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ru","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Yeh","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,11]]},"reference":[{"key":"4763_CR1","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","volume":"372","author":"BM Mathers","year":"2008","unstructured":"Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, et al: Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008, 372: 1733-1745. 10.1016\/S0140-6736(08)61311-2.","journal-title":"Lancet"},{"key":"4763_CR2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","volume":"378","author":"PK Nelson","year":"2011","unstructured":"Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L: Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011, 378: 571-583. 10.1016\/S0140-6736(11)61097-0.","journal-title":"Lancet"},{"key":"4763_CR3","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1128\/jcm.35.12.3274-3277.1997","volume":"35","author":"SA Villano","year":"1997","unstructured":"Villano SA, Vlahov D, Nelson KE, Lyles CM, Cohn S, Thomas DL: Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J Clin Microbiol. 1997, 35: 3274-3277.","journal-title":"J Clin Microbiol"},{"key":"4763_CR4","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/00126334-200312010-00007","volume":"34","author":"E Pisani","year":"2003","unstructured":"Pisani E, Dadun , Sucahya PK, Kamil O, Jazan S: Sexual behavior among injection drug users in 3 indonesian cities carries a high potential for HIV spread to noninjectors. J Acquir Immune Defic Syndr. 2003, 34: 403-406. 10.1097\/00126334-200312010-00007.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4763_CR5","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/aje\/kwf222","volume":"157","author":"DC Des Jarlais","year":"2003","unstructured":"Des Jarlais DC, Diaz T, Perlis T, Vlahov D, Maslow C, Latka M, Rockwell R, Edwards V, Friedman SR, Monterroso E, et al: Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol. 2003, 157: 467-471. 10.1093\/aje\/kwf222.","journal-title":"Am J Epidemiol"},{"key":"4763_CR6","volume-title":"2006 Report on the global AIDS epidemic. Geneva: joint UN programme on HIV\/AIDS","author":"UNAIDS","year":"2006","unstructured":"UNAIDS: 2006 Report on the global AIDS epidemic. Geneva: joint UN programme on HIV\/AIDS. 2006"},{"key":"4763_CR7","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1001\/archinte.166.15.1632","volume":"166","author":"R Weber","year":"2006","unstructured":"Weber R, Sabin CA, Friis-Moller N, Reiss P, El-Sadr WM, Kirk O, Dabis F, Law MG, Pradier C, De Wit S, et al: Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006, 166: 1632-1641.","journal-title":"Arch Intern Med"},{"key":"4763_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/ije\/dyh307","volume":"34","author":"C Lewden","year":"2005","unstructured":"Lewden C, Salmon D, Morlat P, Bevilacqua S, Jougla E, Bonnet F, Heripret L, Costagliola D, May T, Chene G: Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol. 2005, 34: 121-130.","journal-title":"Int J Epidemiol"},{"key":"4763_CR9","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1128\/JCM.40.8.3047-3049.2002","volume":"40","author":"JH Kao","year":"2002","unstructured":"Kao JH, Chen PJ, Lai MY, Chen DS: Hepatitis D virus genotypes in intravenous drug users in taiwan: decreasing prevalence and lack of correlation with hepatitis B virus genotypes. J Clin Microbiol. 2002, 40: 3047-3049. 10.1128\/JCM.40.8.3047-3049.2002.","journal-title":"J Clin Microbiol"},{"key":"4763_CR10","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/jmv.21481","volume":"81","author":"FY Chu","year":"2009","unstructured":"Chu FY, Chiang SC, Su FH, Chang YY, Cheng SH: Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan. J Med Virol. 2009, 81: 973-978. 10.1002\/jmv.21481.","journal-title":"J Med Virol"},{"key":"4763_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1023\/A:1007662315835","volume":"15","author":"CJ Chang","year":"1999","unstructured":"Chang CJ, Lin CH, Lee CT, Chang SJ, Ko YC, Liu HW: Hepatitis C virus infection among short-term intravenous drug users in southern Taiwan. Eur J Epidemiol. 1999, 15: 597-601. 10.1023\/A:1007662315835.","journal-title":"Eur J Epidemiol"},{"key":"4763_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1747-597X-6-6","volume":"6","author":"TS Lee","year":"2011","unstructured":"Lee TS, Shen HC, Wu WH, Huang CW, Yen MY, Wang BE, Chuang P, Shih CY, Chou YC, Liu YL: Clinical characteristics and risk behavior as a function of HIV status among heroin users enrolled in methadone treatment in northern Taiwan. Subst Abuse Treat Prev Policy. 2011, 6: 6-10.1186\/1747-597X-6-6.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"4763_CR13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S0929-6646(09)60231-X","volume":"106","author":"CH Chen","year":"2007","unstructured":"Chen CH, Yang PM, Huang GT, Lee HS, Sung JL, Sheu JC: Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formos Med Assoc. 2007, 106: 148-155. 10.1016\/S0929-6646(09)60231-X.","journal-title":"J Formos Med Assoc"},{"key":"4763_CR14","unstructured":"Taiwan Centers for Disease Control and Prevention: Surveillance of HIV. Taipei, Taiwan: CDC, http:\/\/www.cdc.gov.tw\/ [accessed 1 Febrary 2012]. [Chinese]"},{"key":"4763_CR15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1097\/00126334-200406010-00012","volume":"36","author":"CL Miller","year":"2004","unstructured":"Miller CL, Wood E, Spittal PM, Li K, Frankish JC, Braitstein P, Montaner JS, Schechter MT: The future face of coinfection: prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users. J Acquir Immune Defic Syndr. 2004, 36: 743-749. 10.1097\/00126334-200406010-00012.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4763_CR16","doi-asserted-by":"publisher","first-page":"e3608","DOI":"10.1371\/journal.pone.0003608","volume":"3","author":"Y Tan","year":"2008","unstructured":"Tan Y, Wei QH, Chen LJ, Chan PC, Lai WS, He ML, Kung HF, Lee SS: Molecular epidemiology of HCV monoinfection and HIV\/HCV coinfection in injection drug users in Liuzhou, Southern China. PLoS One. 2008, 3: e3608-10.1371\/journal.pone.0003608.","journal-title":"PLoS One"},{"key":"4763_CR17","first-page":"318","volume":"13","author":"M Hosseini","year":"2010","unstructured":"Hosseini M, SeyedAlinaghi S, Kheirandish P, Esmaeli Javid G, Shirzad H, Karami N, Jahani M, Seyed Ahmadian M, Payvarmehr F, Mohraz M, et al: Prevalence and correlates of co-infection with human immunodeficiency virus and hepatitis C virus in male injection drug users in Iran. Arch Iran Med. 2010, 13: 318-323.","journal-title":"Arch Iran Med"},{"key":"4763_CR18","first-page":"1","volume":"52","author":"CDC","year":"2003","unstructured":"CDC: Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR Morb Mortal Wkly Rep. 2003, 52: 1-16.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4763_CR19","first-page":"1","volume":"50","author":"P CfDCa","year":"2001","unstructured":"CfDCa P: Revised guidelines for HIV counseling, testing, and referral. MMWR Morb Mortal Wkly Rep. 2001, 50: 1-58.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4763_CR20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1054\/jcfm.2001.0474","volume":"8","author":"B Marc","year":"2001","unstructured":"Marc B, Bouchez-Buvry A, Wepierre JL, Boniol L, Vaquero P, Garnier M: Carbon-monoxide poisoning in young drug addicts due to indoor use of a gasoline-powered generator. J Clin Forensic Med. 2001, 8: 54-56. 10.1054\/jcfm.2001.0474.","journal-title":"J Clin Forensic Med"},{"key":"4763_CR21","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3201\/eid1605.091446","volume":"16","author":"RS Garfein","year":"2010","unstructured":"Garfein RS, Laniado-Laborin R, Rodwell TC, Lozada R, Deiss R, Burgos JL, Cuevas-Mota J, Cerecer P, Moser K, Volker ML, et al: Latent tuberculosis among persons at risk for infection with HIV, Tijuana, Mexico. Emerg Infect Dis. 2010, 16: 757-763. 10.3201\/eid1605.091446.","journal-title":"Emerg Infect Dis"},{"key":"4763_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/jmv.10554","volume":"72","author":"TI Huo","year":"2004","unstructured":"Huo TI, Wu JC, Wu SI, Chang AL, Lin SK, Pan CH, Huang YH, Chang FY, Lee SD: Changing seroepidemiology of hepatitis B, C, and D virus infections in high-risk populations. J Med Virol. 2004, 72: 41-45. 10.1002\/jmv.10554.","journal-title":"J Med Virol"},{"key":"4763_CR23","first-page":"55","volume":"24","author":"JS Wu","year":"1991","unstructured":"Wu JS, Lu CF, Liu WT, Lin SY: Prevalence of antibodies to hepatitis C virus (anti-HCV) in different populations in Taiwan. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi. 1991, 24: 55-60.","journal-title":"Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi"},{"key":"4763_CR24","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0929-6646(08)60106-0","volume":"107","author":"HC Lee","year":"2008","unstructured":"Lee HC, Ko NY, Lee NY, Chang CM, Ko WC: Seroprevalence of viral hepatitis and sexually transmitted disease among adults with recently diagnosed HIV infection in Southern Taiwan, 2000\u20132005: upsurge in hepatitis C virus infections among injection drug users. J Formos Med Assoc. 2008, 107: 404-411. 10.1016\/S0929-6646(08)60106-0.","journal-title":"J Formos Med Assoc"},{"key":"4763_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/YCO.0b013e328338658b","volume":"23","author":"YP Bao","year":"2010","unstructured":"Bao YP, Liu ZM, Lu L: Review of HIV and HCV infection among drug users in China. Curr Opin Psychiatry. 2010, 23: 187-194. 10.1097\/YCO.0b013e328338658b.","journal-title":"Curr Opin Psychiatry"},{"key":"4763_CR26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1503\/cmaj.060416","volume":"177","author":"L Calzavara","year":"2007","unstructured":"Calzavara L, Ramuscak N, Burchell AN, Swantee C, Myers T, Ford P, Fearon M, Raymond S: Prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities. CMAJ. 2007, 177: 257-261. 10.1503\/cmaj.060416.","journal-title":"CMAJ"},{"key":"4763_CR27","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1080\/09540120902862584","volume":"21","author":"J Mahanta","year":"2009","unstructured":"Mahanta J, Borkakoty B, Das HK, Chelleng PK: The risk of HIV and HCV infections among injection drug users in northeast India. AIDS Care. 2009, 21: 1420-1424. 10.1080\/09540120902862584.","journal-title":"AIDS Care"},{"key":"4763_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1258\/ijsa.2008.008362","volume":"20","author":"YP Bao","year":"2009","unstructured":"Bao YP, Liu ZM: Systematic review of HIV and HCV infection among drug users in China. Int J STD AIDS. 2009, 20: 399-405. 10.1258\/ijsa.2008.008362.","journal-title":"Int J STD AIDS"},{"key":"4763_CR29","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s11524-009-9417-9","volume":"87","author":"MC Clatts","year":"2010","unstructured":"Clatts MC, Colon-Lopez V, le Giang M, Goldsamt LA: Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection. J Urban Health. 2010, 87: 278-291. 10.1007\/s11524-009-9417-9.","journal-title":"J Urban Health"},{"key":"4763_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10461-005-9055-5","volume":"10","author":"SA Strathdee","year":"2006","unstructured":"Strathdee SA, Patterson TL: Behavioral interventions for HIV-positive and HCV-positive drug users. AIDS Behav. 2006, 10: 115-130. 10.1007\/s10461-005-9055-5.","journal-title":"AIDS Behav"},{"key":"4763_CR31","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1186\/1471-2458-9-492","volume":"9","author":"K Hayashi","year":"2009","unstructured":"Hayashi K, Milloy MJ, Fairbairn N, Kaplan K, Suwannawong P, Lai C, Wood E, Kerr T: Incarceration experiences among a community-recruited sample of injection drug users in Bangkok, Thailand. BMC Publ Health. 2009, 9: 492-10.1186\/1471-2458-9-492.","journal-title":"BMC Publ Health"},{"key":"4763_CR32","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrn3104","volume":"12","author":"A Badiani","year":"2011","unstructured":"Badiani A, Belin D, Epstein D, Calu D, Shaham Y: Opiate versus psychostimulant addiction: the differences do matter. Nat Rev Neurosci. 2011, 12: 685-700. 10.1038\/nrn3104.","journal-title":"Nat Rev Neurosci"},{"key":"4763_CR33","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/00126334-200104150-00014","volume":"26","author":"CF Kwiatkowski","year":"2001","unstructured":"Kwiatkowski CF, Booth RE: Methadone maintenance as HIV risk reduction with street-recruited injecting drug users. J Acquir Immune Defic Syndr. 2001, 26: 483-489.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4763_CR34","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1002\/hep.1840360713","volume":"36","author":"NA Terrault","year":"2002","unstructured":"Terrault NA: Sexual activity as a risk factor for hepatitis C. Hepatology. 2002, 36: S99-S105.","journal-title":"Hepatology"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-12-1066.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-12-1066\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-12-1066","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-12-1066.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:08:49Z","timestamp":1630530529000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-12-1066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["4763"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-12-1066","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"21 May 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"1066"}}